The contract research organization posted revenue of $2 billion in the period, which missed Street forecasts. Six analysts surveyed by Zacks expected $2.01 billion. Icon PLC expects full-year ...

Before you invest in ICON PLC (ICLR), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy. Zacks ...

Barclays analyst Richard Taylor maintained a Buy rating on SSP Group plc (SSPG – Research Report) today and set a price target of £2.40. The ...

Headquartered in Dublin, Ireland, ICON Public Limited Company (NASDAQ:ICLR) is a clinical research organization. The one-month return of ICON Public Limited Company (NASDAQ:ICLR) was -13.11% ...

In a report released today, Jonathan Hurn from Barclays maintained a Buy rating on IMI plc (IMI – Research Report). The company’s shares closed ...

ICON plc ICLR posted first-quarter 2025 adjusted ... Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is among the most innovative ...

Barclays on Thursday downgraded the contract research organizations IQVIA Holdings (NYSE:IQV), ICON PLC (NASDAQ:ICLR), and Fortrea Holdings (NASDAQ:FTRE), arguing that the Trump administration’s ...